|
|
|
|
B-004 / B-004-1ML updated item number format
Benzoylecgonine
1.0 mg/mL in Methanol | Certified Reference Material
|
|
Benzoylecgonine is the primary metabolite of cocaine and a major biomarker for determination of cocaine use. This certified reference standard is suitable for a variety of LC/MS or GC/MS applications from forensic analysis and clinical toxicology to urine drug testing. Benzoylecgonine is also the main pharmaceutical ingredient in the prescription drug Esterom, a topical analgesic used for the relief of muscle pain.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
519-09-5
|
| Chemical Formula:
|
C16H19NO4
|
| Molecular Weight:
|
289.33
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| B-001 / B-001-1ML |
|
Benzoylecgonine-D3, 100 μg/mL
|
|
$40.80
|
|
|
|
|
|
| B-008 / B-008-1ML |
|
Benzoylecgonine-D3, 1.0 mg/mL
|
|
$164.00
|
|
|
|
|
|
| B-013 / B-013-1ML |
|
Benzoylecgonine-D8, 100 μg/mL
|
|
$42.30
|
|
|
|
|
|
| B-014 / B-014-1ML |
|
Benzoylecgonine-D8, 1.0 mg/mL
|
|
$161.00
|
|
|
|
|
|
| C-009 / C-009-1ML |
|
Cocaethylene-D3 (Benzoylecgonine ethyl ester-D3), 100 μg/mL
|
|
$43.90
|
|
|
|
|
|
| C-010 / C-010-1ML |
|
Cocaethylene (Benzoylecgonine ethyl ester), 1.0 mg/mL
|
|
$33.60
|
|
|
|
|
|
| C-024 / C-024-1ML |
|
Cocaethylene-D8 (Benzoylecgonine ethyl ester-D8), 100 μg/mL
|
|
$45.20
|
|
|
|
|
|
| C-088 / C-088-1ML |
|
Cocaine Multi-Component Mixture-4, 250 μg/mL of each component
|
|
$206.00
|
|
|
|
|
|
| H-017 / H-017-1ML |
|
m-Hydroxybenzoylecgonine, 1.0 mg/mL
|
|
$248.00
|
|
|
|
|
|
| H-119 / H-119-1ML |
|
m-Hydroxycocaine, 1.0 mg/mL
|
|
$226.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1044 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ Accelerated Stability Studies by High Performance Liquid Chromatography | Greg Serna, Tamara Tarbox, Isil Dilek, Cerilliant, 2012
|
|
▶ Advanced Toxicology Testing for Compounds using Core-Shell Technology | Erica A. Guice, Jessica Marsh, Seyed Sajadi, and Matthew Pentis, Western Slope Laboratory, 2012
|
|
▶ Fast and Sensitive Target Compound Quantification and Confirmation with a New Triple Quadrupole Acquisition Function | Michael Flanagan, Agilent Technologies, Inc., 2011
|
|
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Testing and Quantification of a Representative Panel of Illicit Drugs in Urine and Serum Using LC-Time-of-Flight Mass Spectrometry | Avinash Dalmia, Noelle M. Elliott, Joanne Mather, Bonnie Marmor, George Perkins;, PerkinElmer, Inc., 2014
|
|
▶ Ultra Fast Analysis of the Cocaine Metabolite (BZE) in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System | Kari E. Schlicht and Vaughn P. Miller, Agilent Technologies, Inc., 2012
|
|
▶ Utilizing Novel SPME LC Tips for Forensic Screening of Drugs of Abuse in Urine Samples | Sigma-Aldrich®, 2015
|
|
|
|
|